1-3 of 3
Paolo Castellucci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Stefano Fanti, MD, Vittorio Stefoni, MD, Gerardo Musuraca, MD, Paolo Castellucci, MD, Enrica Marchi, MD, Mariapaola Fina, MD, Michele Baccarani, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2431.
https://doi.org/10.1182/blood.V108.11.2431.2431
Published: 2006
Journal Articles

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, MD, PhD, Alessandro Pulsoni, MD, Manuela Balocco, MD, Monica Tani, MD, Stefano Fanti, MD, Alessio Perrotti, MD, Paolo Castellucci, MD, Francesco Zaja, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Maria Teresa Voso, MD, Pierpaolo Fattori, MD, Luciano Guardigni, MD, Patrizia Gentilini, MD, Maria Giuseppina Cabras, MD, Amalia De Renzo, MD, Luigi Rigacci, MD
Journal: Blood
Blood (2006) 108 (11): 2479.
https://doi.org/10.1182/blood.V108.11.2479.2479
Published: 2006
Journal Articles

Role of 18f-FDG PET/CT in the Management of Multiple Myeloma.

Elena Zamagni, Cristina Nanni, Patrizia Tosi, Stefano Fanti, Delia Cangini, Paolo Castellucci, Paola Tacchetti, Giulia Perrone, Michela Ceccolini, Mohsen Farsad, Michele Baccarani, Michele Cavo
Journal: Blood
Blood (2005) 106 (11): 3492.
https://doi.org/10.1182/blood.V106.11.3492.3492
Published: 2005